Revise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of India Dr. Divya Colin4 March 2023 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the vaccine maker Serum Institute of India to conduct Phase II/III clinical trial of Yellow Fever...
NPPA revises ceiling price of 80 scheduled formulations, details Dr. Divya Colin3 March 2023 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemical & Fertilizers, the...
NPPA Fixes Ceiling Price of Hydrocortisone 20mg Tablet Dr. Divya Colin2 March 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price for Hydrocortisone 20mg tablet at...
Dr Reddy's gets CDSCO panel nod to study Darbepoetin alfa Dr. Divya Colin1 March 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
NPPA Fixes Retail Price Of 74 Formulations, Details Dr. Divya Colin28 Feb 2023 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizer, the...
Submit Phase II CT safety data: CDSCO panel tells Pfizer over Ritlecitinib Dr. Divya Colin27 Feb 2023 6:00 PM ISTNew Delhi: Denying the proposal presented by the pharma major Pfizer for Phase III CT of the drug Ritlecitinib, the Subject Expert Committee (SEC)...
Submit justification: CDSCO Panel tells Hetero for FDC Lacosamide, Brivaracetam Dr. Divya Colin26 Feb 2023 6:00 PM ISTNew Delhi: In line with the drug maker Hetero Pharma's proposal for the fixed-dose combination Lacosamide plus Brivaracetam, the Subject Expert...
Eli Lilly Gets CDSCO Panel Nod To Import, Market Lasmiditan for acute treatment of migraine Dr. Divya Colin25 Feb 2023 6:00 PM ISTNew Delhi: Citing that the global clinical trial data demonstrate the efficacy and safety of Lasmiditan for the acute treatment of migraine with and...
Sun Pharma Gets CDSCO panel nod to manufacture, market antidiabetic FDC drug Dr. Divya Colin24 Feb 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional...
Rajeev Singh Raghuvanshi takes charge as new Drugs Controller General of India Farhat Nasim23 Feb 2023 11:21 AM ISTNew Delhi: Rajeev Singh Raghuvanshi has been appointed as the new Drugs Controller General of India (DCGI), Central Drugs Standard Control...
CDSCO Drug Alert: 67 Drug Samples Including Sun Pharma Pantocid DSR, Alkem's Pan -D flagged Susmita Roy22 Feb 2023 5:47 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 67 medicine...
CDSCO panel seeks data for Eli Lilly's anticancer drug selpercatinib Dr. Divya Colin21 Feb 2023 6:00 PM ISTNew Delhi: In response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg...
